eli lilly news glp-1 Retatrutide, the next generation of drug from Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage clinical trial, the company announced. In New Eli Lilly drug retatrutide

Losing muscle is

Originally developed for managing type 2 diabetes, these medications are now being explored as potential solutions for weight and metabolic issues in women with PCOS (Polycystic Ovary Syndrome).But as their popularity increases, we n

Lipedema is a challenging and often misunderstood condition characterized by the abnormal accumulation of fat in the legs, arms, and other areas of the body

Millions of Medicare beneficiaries could save tens of thousands a year as the Feds make a multibillion dollar bet.

A side-by-side editorial look at Compounded Semaglutide vs Wegovy: mechanism, FDA status, real-world cost, and the GLP-1 pathway genetics most providers don'

Vitamin A (as Beta Carotene, Retinyl Acetate)